Cargando…
Cysteinyl Leukotriene Receptor Antagonists Decrease Cancer Risk in Asthma Patients
Previous in vitro and in vivo studies have demonstrated the potential of using cysteinyl leukotriene receptor antagonists (LTRAs) for chemoprevention, but this has not been investigated in any clinical setting. We therefore investigated the chemopreventive effect of LTRAs in a nationwide population-...
Autores principales: | Tsai, Ming-Ju, Wu, Ping-Hsun, Sheu, Chau-Chyun, Hsu, Ya-Ling, Chang, Wei-An, Hung, Jen-Yu, Yang, Chih-Jen, Yang, Yi-Hsin, Kuo, Po-Lin, Huang, Ming-Shyan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4823742/ https://www.ncbi.nlm.nih.gov/pubmed/27052782 http://dx.doi.org/10.1038/srep23979 |
Ejemplares similares
-
Corrigendum: Cysteinyl Leukotriene Receptor Antagonists Decrease Cancer Risk in Asthma Patients
por: Tsai, Ming-Ju, et al.
Publicado: (2016) -
Cysteinyl Leukotriene Pathway and Cancer
por: Tsai, Ming-Ju, et al.
Publicado: (2021) -
Adipokines and Cysteinyl Leukotrienes in the Pathogenesis of Asthma
por: Coffey, Michael J., et al.
Publicado: (2015) -
Montelukast: More than a Cysteinyl Leukotriene Receptor Antagonist?
por: Tintinger, Gregory R., et al.
Publicado: (2010) -
Cysteinyl Leukotriene Receptor Antagonists Associated With a Decreased Incidence of Cancer: A Retrospective Cohort Study
por: Jang, Ha Young, et al.
Publicado: (2022)